Data / Form D filings / Trace Biosciences Inc.
Trace Biosciences Inc.: Form D filing
Trace Biosciences Inc., a biotechnology company in Beaverton, OR, filed a Form D with the SEC in 2026. The latest, on August 12, 2026, reports $8.3 million sold of a $16.2 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1800 NW 167TH PL STE 160, Beaverton, OR, 97006
- Phone
- (971) 202-0545
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2147501
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | New notice | $16,234,498 | $8,334,499 | $7,899,999 | 19 | Jul 28, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Connor Barth | Executive Officer, Director | |
| Summer Gibbs | Executive Officer, Director | |
| Lei Wang | Executive Officer, Director | |
| Jonathan Sorger | Director |
Other biotechnology companies in Oregon that filed recently
- UBIVAC, INC. $80,000 · Aug 27, 2026
Every Form D from the week of Aug 10, 2026 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Trace Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.